Point72 Asset Management, L.P. 13D/13G Filings for Bicycle Therapeutics plc (BCYC)

Point72 Asset Management, L.P. 13D and 13G filings for Bicycle Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:34 pm
Sale
2025-03-3113GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.3,739,318
7.800%
-490,984decrease
(-11.61%)
Filing
2024-12-20
4:05 pm
Purchase
2024-12-1313GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.4,230,302
8.900%
3,209,134increase
(+314.26%)
Filing
2023-02-14
4:09 pm
Sale
2022-12-3113GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,021,168
3.400%
-551,655decrease
(-35.07%)
Filing
2022-02-14
4:40 pm
Purchase
2021-12-3113GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,572,823
5.300%
135,247increase
(+9.41%)
Filing
2021-02-16
3:25 pm
Purchase
2020-12-3113GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,437,576
6.700%
334,600increase
(+30.34%)
Filing
2020-09-15
4:32 pm
Purchase
2020-09-1413GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,102,976
5.700%
1,102,976increase
(New Position)
Filing